Outcomes of Hypofractional Tomotherapy in Patients with Stage III Nonsmall Cell Lung Cancer Who Are Not Eligible for Surgery or Concurrent Chemoradiation

Outcomes of Hypofractional Tomotherapy in Patients with Stage III Nonsmall Cell Lung Cancer Who Are Not Eligible for Surgery or Concurrent Chemoradiation

Purpose. We assessed the clinical outcomes and toxicities following hypofractionation with helical tomographic intensity-modulated radiotherapy technology (tomotherapy) in patients with stage III non-small cell lung cancer (NSCLC) who were not candidates for surgery or concurrent chemoradiation. Met...

Full description

Bibliographic Details
Main Authors: Jing Li, Hongqi Li, Yingjie Wang, Junyang Liu, Xuan Wang, Haifeng Pang, Dongshu Chang, Yupeng Di, Gang Ren, Ping Li, Yong Wang, Chen Liu, Xiao Chen, Xiaoli Kang, Tingyi Xia
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2020/9168424

Internet

http://dx.doi.org/10.1155/2020/9168424

Similar Items